Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Legal

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Government
  • Legal
  • Media
  • News
  • Regulations
  • Tech

EU Pulls out the Big Guns: Record Privacy Fine on the Horizon for Meta

By Anusuya Lahiri
May 18, 9:01 AM
Meta Platforms, Inc (NASDAQ:META) will likely face a record European Union privacy fine related to data transfer of Facebook’s…

AMZN

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

Walgreens Settles Opioid Epidemic Lawsuit with San Francisco for $230M, Says It Does Not Admit Fault

By Vandana Singh
May 18, 8:39 AM
Walgreens Boots Alliance Inc (NASDAQ: WBA) reached a $230 million settlement with San Francisco to settle claims regarding its role in the city's opioid epidemic.

WBA

Read More
2 minute read
  • Legal
  • Media
  • News
  • Top Stories

Deutsche Bank To Reportedly Pay $75M To Settle Jeffrey Epstein Accusers’ Suit: ‘Groundbreaking,’ Say Plaintiffs’ Lawyers

By Aveek Bhowmik
May 18, 12:19 AM
Deutsche Bank AG (NYSE:DB) has agreed to pay $75 million to settle a proposed class-action lawsuit that accused…

DB

Read More
2 minute read
  • Cannabis
  • Legal
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

The Psychedelic Mushrooms Market; Between Legitimate Harvesting And Illegal Retail Sales

By Lara Goldstein
May 17, 6:55 PM
While psychedelics reform is clearly gaining momentum, not only in the U.S. but notably in places like Australia and less so Canada. The fact is, all compounds remain currently Schedule I drugs (or equivalents) and thus federally illegal in many countries including the U.S.

OPTHF

Read More
1 minute read
  • General
  • Government
  • Health Care
  • Large Cap
  • Legal
  • News

Johnson & Johnson Sets Aside $400M To End US State Consumer Protection Claims

By Vandana Singh
May 17, 8:20 AM
As a part of the $8.9 billion effort to settle claims related to talc products, Johnson & Johnson (NYSE:

JNJ

Read More
1 minute read
  • Biotech
  • General
  • Government
  • Health Care
  • Large Cap
  • Legal
  • M&A
  • Movers
  • News
  • Top Stories
  • Trading Ideas

FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A

By Vandana Singh
May 16, 2:37 PM
In a rare move to block a large pharma deal, the U.S.

AMGN

Read More
2 minute read
  • Cryptocurrency
  • Legal
  • Markets
  • News
  • Penny Stocks

BlockFi’s $240M Disaster: The Blame Game And The Lost Millions

By Murtuza Merchant
May 16, 12:10 PM
Tensions have escalated between the BlockFi Creditors Committee and the beleaguered digital asset lender's management, with the former rebuffing BlockFi's assertion that it fell victim to FTX and Alameda Research 

BTC

Read More
1 minute read
  • Legal
  • M&A
  • Management
  • News

Horizon Therapeutics Responds To U.S. Federal Trade Commission Action To Block Acquisition By Amgen

By Happy Mohamed
May 16, 11:47 AM
Horizon Therapeutics plc (NASDAQ:HZNP) today issued the following statement in response to the FTC's complaint seeking to block Amgen's proposed acquisition of the Company: "This acquisition has the

AMGN

Read More
1 minute read
  • Legal
  • M&A
  • Management
  • News

Amgen Responds To FTC Action Re: Proposed Acquisition Of Horizon Therapeutics; Says Disappointed By The FTC’s Decision And Remains Committed To Completing This Acquisition

By Happy Mohamed
May 16, 11:32 AM
 Amgen (NASDAQ:AMGN) today issued the following statement in response to the U.S. Federal Trade Commission's (FTC) complaint seeking to block the company's proposed acquisition of Horizon Therapeutics

AMGN

Read More
3 minute read
  • Legal
  • News

‘North Carolina Lawmakers Approve Bill To Create $5 Million Psychedelic Research Grant Fund In Committee’ – Marijuana Moment

By Happy Mohamed
May 16, 10:20 AM
https://www.marijuanamoment.net/north-carolina-lawmakers-approve-bill-to-create-5-million-psychedelic-research-grant-fund-in-committee/ A North Carolina House committee has approved a bill to create a $5 million grant

CMPS

Posts pagination

Previous 1 … 123 124 125 … 258 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service